Draegerwerk AG & Co KGaA (ETR:DRW3) PT Set at €50.00 by Independent Research

Share on StockTwits

Draegerwerk AG & Co KGaA (ETR:DRW3) received a €50.00 ($58.14) price objective from stock analysts at Independent Research in a research report issued on Tuesday, Borsen Zeitung reports. The brokerage presently has a “sell” rating on the stock. Independent Research’s price objective indicates a potential downside of 3.29% from the stock’s current price.

A number of other brokerages also recently issued reports on DRW3. HSBC set a €50.00 ($58.14) price target on Draegerwerk AG & Co KGaA and gave the company a “neutral” rating in a report on Tuesday, November 5th. Hauck & Aufhaeuser set a €38.00 ($44.19) price target on Draegerwerk AG & Co KGaA and gave the company a “sell” rating in a report on Monday. Nord/LB set a €45.00 ($52.33) price target on Draegerwerk AG & Co KGaA and gave the company a “sell” rating in a report on Friday, December 6th. Kepler Capital Markets set a €43.00 ($50.00) price target on Draegerwerk AG & Co KGaA and gave the company a “sell” rating in a report on Monday. Finally, Warburg Research set a €56.00 ($65.12) price target on Draegerwerk AG & Co KGaA and gave the company a “neutral” rating in a report on Tuesday. Four analysts have rated the stock with a sell rating and three have assigned a hold rating to the company’s stock. Draegerwerk AG & Co KGaA presently has a consensus rating of “Sell” and an average target price of €46.86 ($54.49).

Shares of ETR:DRW3 opened at €51.70 ($60.12) on Tuesday. Draegerwerk AG & Co KGaA has a 12-month low of €38.32 ($44.56) and a 12-month high of €59.40 ($69.07). The company has a market capitalization of $409.64 million and a PE ratio of 35.75. The business has a 50 day moving average of €54.92 and a two-hundred day moving average of €50.25. The company has a current ratio of 1.93, a quick ratio of 1.09 and a debt-to-equity ratio of 31.33.

About Draegerwerk AG & Co KGaA

Dr├Ągerwerk AG & Co KGaA develops equipment and solutions in the fields of medical and safety technology in Europe, Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care.

Featured Story: What is the FTSE 100 index?

Analyst Recommendations for Draegerwerk AG & Co KGaA (ETR:DRW3)

Receive News & Ratings for Draegerwerk AG & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Draegerwerk AG & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Hasbro, Inc.  Expected to Earn Q1 2020 Earnings of $0.01 Per Share
Hasbro, Inc. Expected to Earn Q1 2020 Earnings of $0.01 Per Share
Halozyme Therapeutics, Inc.  to Post Q1 2020 Earnings of  Per Share, Piper Sandler Forecasts
Halozyme Therapeutics, Inc. to Post Q1 2020 Earnings of Per Share, Piper Sandler Forecasts
Q1 2020 EPS Estimates for Helios Technologies  Boosted by William Blair
Q1 2020 EPS Estimates for Helios Technologies Boosted by William Blair
Aergo Price Down 15.4% This Week
Aergo Price Down 15.4% This Week
Skychain  Market Capitalization Achieves $662,118.00
Skychain Market Capitalization Achieves $662,118.00
EveriToken  Trading Down 27.4% Over Last Week
EveriToken Trading Down 27.4% Over Last Week


 
© 2006-2020 Zolmax.